Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
55.87
+4.37 (8.49%)
Jul 10, 2026, 3:00 PM CST
Chengdu Easton Biopharmaceuticals Company Description
Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally.
The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs.
Its products are used in oncology, cardiovascular, neurology and psychiatry, anesthetic and analgesics, urinary, anti-inflammatory, anti-diabetes, anthelmintic, and antiemetic therapeutic categories.
The company was founded in 2009 and is headquartered in Chengdu, China.
Chengdu Easton Biopharmaceuticals Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,480 |
| CEO | Mingxu Yuan |
Contact Details
Address: No. 8, Ankang Road Chengdu, 610200 China | |
| Phone | 86 28 8782 7191 |
| Website | eastonpharma.cn |
Stock Details
| Ticker Symbol | 688513 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004397 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mingxu Yuan | GM and Director |
| Xiao Qin Bo | Chief Financial Officer, Accounting Supervisor and Director |
| Daming Zhang | Deputy GM and Director |
| Shuyun Li | Board Secretary |
| Zheng Pin Guan | Deputy GM and Core Technician |
| Xingyao Song | Deputy General Manager |
| Avinash Ramkisan Mane | Chief Scientist of Formulation Research Department and Core Technician |
| Haibin Guo | Manager of Formulation Research Department and Core Technician |